A Matrix-based Model Predicts Primary Response to Infliximab in Crohn’s Disease

Obesity in Inflammatory Bowel Disease: A Marker of Less Severe Disease

(2015) Avegail Flores et al.   DIGESTIVE DISEASES AND SCIENCES

Role for Therapeutic Drug Monitoring During Induction Therapy with TNF Antagonists in IBD

(2015) Konstantinos Papamichael et al.   INFLAMMATORY BOWEL DISEASES

Systematic review with meta-analysis: inflammatory bowel disease in the elderly

(2014) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mo1179 Efficacy and Safety of Anti-TNF Therapy in Elderly Patients With Inflammatory Bowel Disease

(2014) Triana Lobatón Ortega et al.   GASTROENTEROLOGY

Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease

(2014) Iris Dotan et al.   INFLAMMATORY BOWEL DISEASES

Serological markers associated with disease behavior and response to anti-tumor necrosis factor therapy in ulcerative colitis

(2014) David Kevans et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Human SNP Links Differential Outcomes in Inflammatory and Infectious Disease to a FOXO3-Regulated Pathway

(2013) James C. Lee et al.   CELL

Targeting TNF-α for the treatment of inflammatory bowel disease

(2013) Thomas Billiet et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Increased Body Mass Index Is Associated with Earlier Time to Loss of Response to Infliximab in Patients with Inflammatory Bowel Disease

(2013) Jason W. Harper et al.   INFLAMMATORY BOWEL DISEASES

Risk Matrix for Prediction of Advanced Disease in a Population-based Study of Patients with Crohnʼs Disease (the IBSEN Study)

(2013) Inger C. Solberg et al.   INFLAMMATORY BOWEL DISEASES

Using Genetic Prediction from Known Complex Disease Loci to Guide the Design of Next-Generation Sequencing Experiments

(2013) Luke Jostins et al.   PLoS One

Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays

(2012) N. Vande Casteele et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease

(2012) Luke Jostins et al.   NATURE

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Safety

(2011) Gert Van Assche et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Predicting the outcome of ankylosing spondylitis therapy

(2011) N. Vastesaeger et al.   ANNALS OF THE RHEUMATIC DISEASES

Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease

(2011) Carlos González-Juanatey et al.   ARTHRITIS RESEARCH & THERAPY

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose and How to Predict Response?

(2010) Geert R D'Haens et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Disease Activity, ANCA and IL23R Genotype Status Determine Early Response to Infliximab in Patients With Ulcerative Colitis

(2010) Matthias Jürgens et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Neuropeptides, Mesenteric Fat, and Intestinal Inflammation

(2009) Iordanes Karagiannides et al.   Annals of the New York Academy of Sciences